China NT Pharma and Hilong raise a combined $342 million

Investors respond well to the Hong Kong IPOs of China NT Pharma and Hilong, helping them to raise a total of $342 million.
China NT Pharma's Suzhou factory
China NT Pharma's Suzhou factory
April 18, 2011

China NT Pharma Group raised HK$1.62 billion ($208 million) in a Hong Kong IPO last week, while Hilong Holdings pocketed HK$1.04 billion ($134 million) after a failed first attempt.

¬ Haymarket Media Limited. All rights reserved.

Sign in to read on!

Registered users get 2 free articles in 30 days.

Subscribers have full unlimited access to FinanceAsia.

Not signed up? New users get 2 free articles per month, plus a 7-day unlimited free trial.

Questions?
See here for more information on licences and prices, or contact [email protected].

Share our publication on social media
Share our publication on social media